Sanofi's Rare Disease subsidiary Genzyme is embarking on a process data analytics initiative to improve processes in manufacturing. Sanofi is also embarking on a core standardization initiative in Manufacturing Quality Operations, with the goal of streamlining the implementation process for new manufacturing technologies across their network. Nick Alexiades will discuss these initiatives and describe how the recently signed Enterprise Agreement will help enable these and future initiatives within Sanofi.